Find Nafamostat manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 81525-10-2, Nafamostat [inn], Nafamstat, (6-carbamimidoylnaphthalen-2-yl) 4-(diaminomethylideneamino)benzoate, Chembl273264, Y25lq0h97d
Molecular Formula
C19H17N5O2
Molecular Weight
347.4  g/mol
InChI Key
MQQNFDZXWVTQEH-UHFFFAOYSA-N
FDA UNII
Y25LQ0H97D

Nafamostat
Nafamostat is a broad-spectrum, synthetic serine protease inhibitor, with anticoagulant, anti-inflammatory, mucus clearing, and potential antiviral activities. Upon administration, nafamostat inhibits the activities of a variety of proteases, including thrombin, plasmin, kallikrein, trypsin, and Cl esterase in the complement system, and factors VIIa, Xa, and XIIa in the coagulation system. Although the mechanism of action of nafamostat is not fully understood, trypsinogen activation in the pancreas is known to be a trigger reaction in the development of pancreatitis. Nafamostat blocks the activation of trypsinogen to trypsin and the inflammatory cascade that follows. Nafamostat may also decrease epithelial sodium channel (ENaC) activity and increase mucus clearance in the airways. ENaC activity is increased in cystic fibrosis. In addition, nafamostat may inhibit the activity of transmembrane protease, serine 2 (TMPRSS2), a host cell serine protease that mediates viral cell entry for influenza virus and coronavirus, thereby inhibiting viral infection and replication.
1 2D Structure

Nafamostat

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(6-carbamimidoylnaphthalen-2-yl) 4-(diaminomethylideneamino)benzoate
2.1.2 InChI
InChI=1S/C19H17N5O2/c20-17(21)14-2-1-13-10-16(8-5-12(13)9-14)26-18(25)11-3-6-15(7-4-11)24-19(22)23/h1-10H,(H3,20,21)(H4,22,23,24)
2.1.3 InChI Key
MQQNFDZXWVTQEH-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1=CC(=CC=C1C(=O)OC2=CC3=C(C=C2)C=C(C=C3)C(=N)N)N=C(N)N
2.2 Other Identifiers
2.2.1 UNII
Y25LQ0H97D
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 6'-amidino-2-naphthyl 4-guanidinobenzoate

2. 6'-amidino-2-naphthyl 4-guanidinobenzoate, Dimethanesulfonate

3. Benzoic Acid, 4-((aminoiminomethyl)amino)-, 6-(aminoiminomethyl)-2-naphthalenyl Ester

4. Benzoic Acid, 4-((aminoiminomethyl)amino)-, 6-(aminoiminomethyl)-2-naphthalenyl Ester, Dihydrochloride

5. Benzoic Acid, 4-((aminoiminomethyl)amino)-, 6-(aminoiminomethyl)-2-naphthalenyl Ester, Dimethanesulfonate

6. Ckd-314

7. Ckd314

8. Fut 175

9. Fut-175

10. Nafamostat Dihydrochloride

11. Nafamostat Mesilate

12. Nafamostat Mesylate

13. Nafamstat Mesilate

14. Ronastat

2.3.2 Depositor-Supplied Synonyms

1. 81525-10-2

2. Nafamostat [inn]

3. Nafamstat

4. (6-carbamimidoylnaphthalen-2-yl) 4-(diaminomethylideneamino)benzoate

5. Chembl273264

6. Y25lq0h97d

7. P-guanidinobenzoic Acid Ester With 6-hydroxy-2-naphthamidine

8. Nafamostat (inn)

9. Benzoic Acid, 4-((aminoiminomethyl)amino)-, 6-(aminoiminomethyl)-2-naphthalenyl Ester

10. 6-carbamimidoylnaphthalen-2-yl 4-guanidinobenzoate

11. Nafamostatum [latin]

12. Nafamostatum

13. Nafamostat Mesylate(fut-175)

14. 6-[amino(imino)methyl]-2-naphthyl 4-{[amino(imino)methyl]amino}benzoate Dimethanesulfonate

15. Ncgc00160398-01

16. 6-amidino2-naphthyl 4-guanidinobenzoate

17. Unii-y25lq0h97d

18. Nafabelltan

19. Ckd314

20. Ckd-314

21. Nafamostat [mi]

22. 6-(aminoiminomethyl)-2-naphthalenyl 4-((aminoiminomethyl)amino)benzoate

23. Nafamostat [who-dd]

24. Bspbio_001194

25. Schembl135503

26. Gtpl4262

27. Dtxsid0048420

28. Amy8858

29. Chebi:135466

30. Hms3742k19

31. Albb-027243

32. Bcp13085

33. Hy-b0190

34. Zinc3874467

35. Bdbm50063698

36. Akos017259237

37. Db12598

38. 6-amidino-2-naphthyl P-guanidinobenzoate

39. Ncgc00160398-02

40. Ncgc00160398-03

41. Ncgc00160398-04

42. Ncgc00160398-13

43. Bs-17665

44. B1177

45. Ft-0629861

46. Fut-175; Fut 175; Fut175

47. D08240

48. Mls-0435512.0001

49. Ab01566816_01

50. 525n102

51. A840154

52. Q15409374

53. (6-carbamimidoyl-2-naphthyl) 4-guanidinobenzoate;nafamostat

54. (6-carbamimidoylnaphthalen-2-yl) 4-carbamimidamidobenzoate

55. 4-guanidino-benzoic Acid 6-carbamimidoyl-naphthalen-2-yl Ester

56. 6-carbamimidoylnaphthalen-2-yl 4-[(diaminomethylidene)amino]benzoate

57. 4-guanidino-benzoic Acid 6-carbamimidoyl-naphthalen-2-yl Ester(fut-175)

58. Benzoic Acid, 4-[(aminoiminomethyl)amino]-,6-(aminoiminomethyl)-2-naphthalenyl Ester

59. Benzoic Acid, 4-[(aminoiminomethyl)amino]-, 6-(aminoiminomethyl)-2-naphthalenyl Ester, Methanesulfonate (1:2)

2.4 Create Date
2005-03-25
3 Chemical and Physical Properties
Molecular Weight 347.4 g/mol
Molecular Formula C19H17N5O2
XLogP32
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count4
Rotatable Bond Count5
Exact Mass347.13822480 g/mol
Monoisotopic Mass347.13822480 g/mol
Topological Polar Surface Area141 Ų
Heavy Atom Count26
Formal Charge0
Complexity552
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Used as an anticoagulant in patients with disseminative blood vessel coagulation, hemorrhagic lesions, and hemorrhagic tendencies. It prevents blood clot formation during extracorporeal circulation in patients undergoing continuous renal replacement therapy and extra corporeal membrane oxygenation.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Nafamostat is a fast-acting proteolytic inhibitor used during hemodialysis to prevent the proteolysis of fibrinogen into fibrin by competitively inhibiting several serine proteases including thrombin. It improves acute pancreatitis and prevents blood clot formation during extracorporeal circulation and has an anti-inflammatory effect in vitro. A study suggets that nafamostat has a neuroprotective role during ischemia-induced brain injury from antithrombin activity.


5.2 MeSH Pharmacological Classification

Complement Inactivating Agents

Compounds that negatively regulate the cascade process of COMPLEMENT ACTIVATION. Uncontrolled complement activation and resulting cell lysis is potentially dangerous for the host. (See all compounds classified as Complement Inactivating Agents.)


Anticoagulants

Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)


Serine Proteinase Inhibitors

Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES. (See all compounds classified as Serine Proteinase Inhibitors.)


Trypsin Inhibitors

Serine proteinase inhibitors which inhibit trypsin. They may be endogenous or exogenous compounds. (See all compounds classified as Trypsin Inhibitors.)


Anti-Inflammatory Agents, Non-Steroidal

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)


Protease Inhibitors

Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). (See all compounds classified as Protease Inhibitors.)


5.3 Absorption, Distribution and Excretion

Route of Elimination

Two metabolites of NM, p-guanidinobenzoic acid (PGBA) and 6-amidino-2-naphthol (AN), are renally excreted. Nafamostat accumulates in the kidneys.


5.4 Metabolism/Metabolites

Nafamostat is mainly hydrolyzed by hepatic carboxyesterase and long-chain acyl-CoA hydrolase in human liver cytosol. Main metabolites are p-guanidinobenzoic acid (PGBA) and 6-amidino-2-naphthol (AN) as inactive protease inhibitors.


5.5 Biological Half-Life

Approximately 8 minutes


5.6 Mechanism of Action

Nafamostat mesilate inhibits various enzyme systems, such as coagulation and fibrinolytic systems (thrombin, Xa, and XIIa), the kallikreinkinin system, the complement system, pancreatic proteases and activation of protease-activated receptors (PARs). Nafamostat inhibits lipopolysaccharide-induced nitric oxide production, apoptosis, and interleukin (IL)-6 and IL-8 levels in cultured human trophoblasts. It is shown to act as an antioxidant in TNF--induced ROS production.


API SUPPLIERS

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1672165800,"product":"NAFAMOSTAT MESILATEJP","address":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N D FLOOR SY NOS 66 & 67 MADHAPUR","city":"HYDERABAD,TELANGANA","supplier":"AURORE LIFE SCIENCES","supplierCountry":"INDIA","foreign_port":"SHANGHAI","customer":"JIANGXI LANGYAN MEDICINE CO.,LTD.","customerCountry":"CHINA","quantity":"1.54","actualQuantity":"1.54","unit":"KGS","unitRateFc":"10000","totalValueFC":"15205.2","currency":"USD","unitRateINR":813636.36363636365,"date":"28-Dec-2022","totalValueINR":"1253000","totalValueInUsd":"15205.2","indian_port":"HYDERABAD AIR","hs_no":"29299090","bill_no":"6501458","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N D FLOOR SY NOS 66 & 67 MADHAPUR, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1679596200,"product":"NAFAMOSTAT MESILATE JP","address":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N D FLOOR SY NOS 66 & 67 MADHAPUR","city":"HYDERABAD,TELANGANA","supplier":"AURORE LIFE SCIENCES","supplierCountry":"INDIA","foreign_port":"SHANGHAI","customer":"JIANGXI LANGYAN MEDICINE CO., LTD.","customerCountry":"CHINA","quantity":"6.60","actualQuantity":"6.6","unit":"KGS","unitRateFc":"10000","totalValueFC":"65665.4","currency":"USD","unitRateINR":818333.33333333337,"date":"24-Mar-2023","totalValueINR":"5401000","totalValueInUsd":"65665.4","indian_port":"HYDERABAD AIR","hs_no":"29252990","bill_no":"8724886","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N D FLOOR SY NOS 66 & 67 MADHAPUR, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1679855400,"product":"NAFAMOSTAT MESILATE","address":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N D FLOOR SY NOS 66 & 67 MADHAPUR","city":"HYDERABAD,TELANGANA","supplier":"AURORE LIFE SCIENCES","supplierCountry":"INDIA","foreign_port":"SHANGHAI","customer":"ZHENJIANG RONGPUJIAN PHARMACEUTICAL","customerCountry":"CHINA","quantity":"6.16","actualQuantity":"6.16","unit":"KGS","unitRateFc":"10000","totalValueFC":"61276.3","currency":"USD","unitRateINR":818181.81818181812,"date":"27-Mar-2023","totalValueINR":"5040000","totalValueInUsd":"61276.3","indian_port":"HYDERABAD AIR","hs_no":"29252990","bill_no":"8801518","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N D FLOOR SY NOS 66 & 67 MADHAPUR, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1679941800,"product":"NAFAMOSTAT MESILATE JP","address":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N D FLOOR SY NOS 66 & 67 MADHAPUR","city":"HYDERABAD,TELANGANA","supplier":"AURORE LIFE SCIENCES","supplierCountry":"INDIA","foreign_port":"SHANGHAI","customer":"JIANGXI LANGYAN MEDICINE CO., LTD.","customerCountry":"CHINA","quantity":"6.16","actualQuantity":"6.16","unit":"KGS","unitRateFc":"10000","totalValueFC":"61276.3","currency":"USD","unitRateINR":818181.81818181812,"date":"28-Mar-2023","totalValueINR":"5040000","totalValueInUsd":"61276.3","indian_port":"HYDERABAD AIR","hs_no":"29252990","bill_no":"8836772","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N D FLOOR SY NOS 66 & 67 MADHAPUR, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1714933800,"product":"NAFAMOSTAT MESILATE","address":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N","city":"HYDERABAD,TELANGANA","supplier":"AURORE LIFE SCIENCES","supplierCountry":"INDIA","foreign_port":"SHANGHAI","customer":"ZHENJIANG RONGPUJIAN PHARMACEUTICAL","customerCountry":"CHINA","quantity":"0.70","actualQuantity":"0.7","unit":"KGS","unitRateFc":"4750","totalValueFC":"3227.7","currency":"USD","unitRateINR":384350,"date":"06-May-2024","totalValueINR":"269045","totalValueInUsd":"3227.7","indian_port":"Hyderabad Air","hs_no":"29251100","bill_no":"9652065","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"JUBILEE HEIGHTS PLOT NO 68 & 69,2N, HYDERABAD,TELANGANA","customerAddress":""}]
28-Dec-2022
06-May-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty